Market data

Select a section

Okyo Pharma Limited NPV

(OKYO)
Sector: Pharmaceuticals & Biotechnology
1.40p
-0.45p -24.32
Last updated: 16:35:11

Company News Headlines

Date Time Headline Source
15/05/2023 07:00 Change of Record Time and Last Day of Dealings RNS
11/05/2023 07:00 Change of Delisting Date to 22 May 2023 RNS
03/05/2023 13:00 Result of Meeting RNS
02/05/2023 07:00 First-Patient First-Visit for Phase 2 Trial RNS
25/04/2023 07:00 Activation of First Clinical Trial Site in the U.S RNS
05/04/2023 07:00 NOTICE OF GENERAL MEETING AND CIRCULAR PUBLICATION RNS
04/04/2023 07:00 Notice Of Intention To Delist From The LSE RNS
30/03/2023 07:00 Director Acquires Shares RNS
29/03/2023 07:00 Director acquires shares RNS
24/03/2023 07:00 Director/PDMR Shareholding RNS
16/03/2023 07:00 Closing of Global Private Placement RNS
15/03/2023 07:01 Director/PDMR Dealings RNS
14/03/2023 07:00 Issue of Equity RNS
06/03/2023 14:00 Price Monitoring Extension RNS
23/02/2023 07:00 Appointment to Scientific Advisory Board RNS
20/02/2023 16:35 Price Monitoring Extension RNS
20/02/2023 14:05 Second Price Monitoring Extn RNS
20/02/2023 14:00 Price Monitoring Extension RNS
20/02/2023 11:05 Second Price Monitoring Extn RNS
20/02/2023 11:00 Price Monitoring Extension RNS
20/02/2023 09:05 Second Price Monitoring Extn RNS
20/02/2023 09:00 Price Monitoring Extension RNS
17/02/2023 16:40 Second Price Monitoring Extn RNS
17/02/2023 16:35 Price Monitoring Extension RNS
14/02/2023 07:00 Allotment of Shares and Total Voting Rights RNS
10/01/2023 16:40 Second Price Monitoring Extn RNS
10/01/2023 16:35 Price Monitoring Extension RNS
10/01/2023 14:05 Second Price Monitoring Extn RNS
10/01/2023 14:00 Price Monitoring Extension RNS
09/01/2023 16:40 Second Price Monitoring Extn RNS
09/01/2023 16:35 Price Monitoring Extension RNS
09/01/2023 14:05 Second Price Monitoring Extn RNS
09/01/2023 14:00 Price Monitoring Extension RNS
03/01/2023 13:15 Interim Results - availability RNS
30/12/2022 07:00 Interim Results for the Six Months Ending 30Sept22 RNS
22/12/2022 07:00 U.S. FDA Clearance of IND Application for OK-101 RNS
06/12/2022 07:00 OKYO files a registration statement with the SEC RNS
01/12/2022 07:00 Change of Auditor RNS
24/11/2022 07:00 Director/PDMR Shareholding RNS
21/11/2022 07:00 U.S. IND Filing on OK-101 for the Treatment of DED RNS
08/09/2022 14:30 OKYO interview on Bloomberg: RedChip Money Report RNS
07/09/2022 13:30 Result of AGM RNS
30/08/2022 07:00 Q4 '22 IND planned followed by P2 with AmbioPharm RNS
19/08/2022 07:00 Notice of AGM RNS
18/08/2022 14:06 Second Price Monitoring Extn RNS
18/08/2022 14:00 Price Monitoring Extension RNS
16/08/2022 07:00 Annual Financial Report RNS
09/06/2022 07:08 Director/PDMR Shareholding RNS
20/05/2022 07:00 Director/PDMR Shareholding RNS
19/05/2022 16:01 Closing of Offering RNS

Market data

Select a section